The legacy of Viagra, and its parent company copyright, presents a complex case study for investors. Originally a blockbuster drug, generating billions in revenue , its intellectual property lapse created a deluge of knock-off medications, significantly diminishing its dominance. While certain pharmaceutical companies may attempt to capitalize on r